急性胆源性胰腺炎胆汁感染病原菌特征及影响因素分析

Analysis of pathogenic bacterial characteristics and influencing factors for bile infection in acute biliary pancreatitis

  • 摘要:
    探讨急性胆源性胰腺炎(ABP)患者胆汁感染病原菌特征及影响因素。
    采用回顾性病例对照研究方法。收集2020年1月至2023年1月宁夏医科大学总医院收治的180例ABP患者的临床资料;男90例,女90例;年龄为(55±17)岁。所有患者行内镜逆行胰胆管造影术(ERCP)中留取胆汁培养。观察指标:(1)胆汁感染病原菌分布及主要病原菌耐药情况。(2)ABP患者发生胆汁感染的影响因素分析。计数资料以绝对数及百分比表示。单因素分析采用χ2检验或独立样本t检验,多因素分析采用Logistic回归模型。
    (1)胆汁感染病原菌分布及主要病原菌耐药情况。180例ABP患者中,64例行ERCP中留取胆汁培养病原菌阳性,阳性率为35.56%(64/180)。64例胆汁培养病原菌阳性的患者中,52例为单一病原菌阳性,12例为混合病原菌阳性。64例患者共检出74株非重复病原菌,其中革兰氏阴性菌40株、革兰氏阳性菌30株、真菌4株。革兰氏阴性菌中,22株大肠埃希菌对头孢曲松、头孢呋辛、头孢他啶、哌拉西林、氨苄西林/舒巴坦耐药率均>70.0%。10株阴沟肠杆菌对头孢曲松、头孢他啶耐药率均>50.0%。8株肺炎克雷伯菌对头孢曲松、头孢呋辛、头孢他啶、哌拉西林、替卡西林、复方新诺明、左氧氟沙星、呋喃妥因耐药率均>70.0%。主要革兰氏阳性菌中,18株屎肠球菌对青霉素、氨苄西林、环丙沙星耐药率均为77.8%(14/18)。8株粪肠球菌对链霉素、庆大霉素、四环素、青霉素耐药率均为37.5%(3/8)。(2)ABP患者发生胆汁感染的影响因素分析。多因素分析结果显示:有ERCP史、有胆囊切除史、合并胰腺坏死均是ABP患者发生胆汁感染的独立危险因素(优势比=3.25、2.90、3.16,95%可信区间为1.17~8.98、1.17~7.19、1.27~7.87,P<0.05)。
    ABP患者胆汁感染主要病原菌为细菌,有ERCP史、有胆囊切除史、合并胰腺坏死均是ABP患者发生胆汁感染的独立危险因素。

     

    Abstract:
    Objective To investigate the pathogenic bacterial characteristics and influen-cing factors for bile infection in acute biliary pancreatitis (ABP).
    Methods The retrospective case-control study was conducted. The clinical data of 180 ABP patients who were admitted to Ningxia Medical University General Hospital from January 2020 to January 2023 were collected. There were 90 males and 90 females, aged (55±17)years. All patients underwent endoscopic retrograde cholangio-pancreatography (ERCP) and bile cultures were collected for testing. Observation indicators: (1) distribution of pathogen in the infected bile and drug resistance of major pathogen; (2) analysis of factors influencing bile infection in ABP patients. Count data were expressed as absolute numbers and percentages. Univariate analysis was conducted using the chi‑square test or independent sample t test, and multivariate analysis was conducted using the Logistic regression model.
    Results (1) Distribution of pathogen in the infected bile and drug resistance of major pathogen. Of the 180 ABP patients, intraoperative bile cultures obtained during ERCP were positive of pathogen in 64 patients, yielding a positivity rate of 35.56%(64/180). Of the 64 patients with positive of pathogen in bile cultures, 52 cases showed single‑pathogen infection and 12 cases showed mix‑pathogen infection. A total of 74 non‑duplicate isolates were recovered from 64 patients, including 40 Gram‑negative bacteria, 30 Gram‑positive bacteria, and 4 fungi. Among the Gram‑negative bacteria, 22 strains of Escherichia coli showed drug resistance rates exceeding 70% to ceftriaxone, cefuroxime, ceftazidime, piperacillin, and ampicillin/sulbactam. Ten strains of Citrobacter freundii showed drug resistance rates exceeding 50.0% to ceftriaxone and ceftazidime. Eight strains of Klebsiella pneumoniae showed drug resistance rates exceeding 70.0% to ceftriaxone, cefuroxime, ceftazidime, piperacillin, ticarcillin, trimethoprim/sulfamethoxazole, levofloxacin, and nitrofurantoin. Among the predominant Gram-positive bacteria, 18 strains of Enterococcus faecalis showed drug resistance rates of 77.8%(14/18) to penicillin, ampicillin, and ciprofloxacin. Eight strains of Enterococcus faecium showed drug resis-tance rates of 37.5%(3/8) to streptomycin, gentamicin, tetracycline, and penicillin. (2) Analysis of factors influencing bile infection in ABP patients. Results of multivariate analysis showed history of ERCP, history of cholecystectomy and pancreatic necrosis were independent risk factors influencing bile infection in ABP patients (odds ratio=3.25, 2.90, 3.16, 95% confidence interval as 1.17-8.98, 1.17-7.19, 1.27-7.87, P<0.05).
    Conclusion The main pathogens causing bile infection in ABP patients are bacteria. History of ERCP, history of cholecystectomy and pancreatic necrosis are independent risk factors influencing bile infection in ABP patients.

     

/

返回文章
返回